Evolve Private Wealth LLC purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA – Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 7,821 shares of the company’s stock, valued at approximately $3,651,000.
Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Norges Bank purchased a new position in HCA Healthcare during the 4th quarter worth $1,262,513,000. Life Cycle Investment Partners Ltd purchased a new position in HCA Healthcare during the 4th quarter worth $374,037,000. Viking Global Investors LP raised its position in HCA Healthcare by 58.5% during the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after buying an additional 690,773 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its position in HCA Healthcare by 4,545.5% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock worth $309,686,000 after buying an additional 649,058 shares during the last quarter. Finally, Danske Bank A S purchased a new position in HCA Healthcare during the 3rd quarter worth $115,530,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.
Wall Street Analyst Weigh In
A number of equities analysts have commented on the stock. Jefferies Financial Group restated a “buy” rating and set a $525.00 price objective on shares of HCA Healthcare in a research report on Friday, April 24th. Robert W. Baird cut their price target on shares of HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating for the company in a report on Wednesday, April 15th. Truist Financial set a $413.00 price target on shares of HCA Healthcare in a report on Thursday, June 4th. UBS Group increased their price target on shares of HCA Healthcare from $598.00 to $635.00 and gave the company a “buy” rating in a report on Monday, February 23rd. Finally, TD Cowen cut their price target on shares of HCA Healthcare from $561.00 to $500.00 and set a “buy” rating for the company in a report on Monday, April 27th. Fifteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $506.14.
HCA Healthcare Trading Down 2.3%
Shares of NYSE HCA opened at $387.87 on Thursday. The stock has a market cap of $86.05 billion, a price-to-earnings ratio of 13.34, a PEG ratio of 1.26 and a beta of 1.12. HCA Healthcare, Inc. has a 52 week low of $330.00 and a 52 week high of $556.52. The company’s 50-day moving average price is $424.54 and its 200 day moving average price is $470.67.
HCA Healthcare (NYSE:HCA – Get Free Report) last issued its quarterly earnings data on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. During the same period in the previous year, the company posted $6.45 earnings per share. HCA Healthcare’s revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, research analysts expect that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.
HCA Healthcare Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be paid a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.73%.
HCA Healthcare Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Read More
- Five stocks we like better than HCA Healthcare
- Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
- CoreWeave Insider Sales Look Big, But Should Investors Worry?
- Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
